Ardelyx’s ambition to revolutionise kidney treatmentA therapy to treat hyperphosphatemia is moving closer to the market after years of development by California-based company Share XArdelyx’s ambition to revolutionise kidney treatmenthttps://pharmaphorum.com/r-d/views-analysis-r-d/ardelyxs-ambition-to-revolutionise-kidney-treatment/
